Risk of Progression and Survival in Multiple Myeloma Relapsing After Therapy with IMiDs and Bortezomib: A Multicenter International Myeloma Working Group Study

Promising new drugs are being evaluated for treatment of multiple myeloma (MM), but their impact should be measured against the expected outcome in patients failing current therapies. However, the natural history of relapsed disease in the current era remains unclear. We studied 286 patients with re...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Kumar, Shaji, Lee, Jae Hoon, Lahuerta, Juan J., Morgan, Gareth, Richardson, Paul G., Crowley, John, Haessler, Jeff, Feather, John, Hoering, Antje, Moreau, Philippe, LeLeu, Xavier, Hullin, Cyrille, Klein, Saskia K., Sonneveld, Pieter, Siegel, David, Bladé, Joan, Goldschmidt, Hartmut, Jagannath, Sundar, San Miguel, Jesus, Orlowski, Robert, Palumbo, Antonio, Sezer, Orhan, Durie, Brian G.M.
Formato: Artigo
Idioma:Inglês
Publicado em: 2011
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4109061/
https://ncbi.nlm.nih.gov/pubmed/21799510
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/leu.2011.196
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados